146 related articles for article (PubMed ID: 33146700)
21. Serum protein profiling reveals an inflammation signature as a predictor of early breast cancer survival.
Karihtala P; Leivonen SK; Puistola U; Urpilainen E; Jääskeläinen A; Leppä S; Jukkola A
Breast Cancer Res; 2024 Apr; 26(1):61. PubMed ID: 38594742
[TBL] [Abstract][Full Text] [Related]
22. The association between plasma chemokines and breast cancer risk and prognosis: A mendelian randomization study.
Yu X; Zhang Y; Lin Y; Zou S; Zhu P; Song M; Fu F; Yang H
Front Genet; 2022; 13():1004931. PubMed ID: 36685922
[No Abstract] [Full Text] [Related]
23. High FLT3 expression indicates favorable prognosis and correlates with clinicopathological parameters and immune infiltration in breast cancer.
Chen R; Wang X; Fu J; Liang M; Xia T
Front Genet; 2022; 13():956869. PubMed ID: 36159964
[No Abstract] [Full Text] [Related]
24. A comprehensive bioinformatics analysis to identify potential prognostic biomarkers among CC and CXC chemokines in breast cancer.
Hozhabri H; Moghaddam MM; Moghaddam MM; Mohammadian A
Sci Rep; 2022 Jun; 12(1):10374. PubMed ID: 35725915
[TBL] [Abstract][Full Text] [Related]
25. Construction of a ceRNA Network and Analysis of Tumor Immune Infiltration in Pancreatic Adenocarcinoma.
Xiao J; Lv C; Xiao C; Ma J; Liao J; Liu T; Du J; Zuo S; Li H; Gu H
Front Mol Biosci; 2021; 8():745409. PubMed ID: 34760926
[TBL] [Abstract][Full Text] [Related]
26. Aberrant DNA methylation impacts gene expression and prognosis in breast cancer subtypes.
Győrffy B; Bottai G; Fleischer T; Munkácsy G; Budczies J; Paladini L; Børresen-Dale AL; Kristensen VN; Santarpia L
Int J Cancer; 2016 Jan; 138(1):87-97. PubMed ID: 26174627
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathological significance and potential drug target of CDH1 in breast cancer: a meta-analysis and literature review.
Huang R; Ding P; Yang F
Drug Des Devel Ther; 2015; 9():5277-85. PubMed ID: 26425077
[TBL] [Abstract][Full Text] [Related]
28. Bioinformatics identification of CCL8/21 as potential prognostic biomarkers in breast cancer microenvironment.
Chen B; Zhang S; Li Q; Wu S; He H; Huang J
Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33146700
[TBL] [Abstract][Full Text] [Related]
29. Revisiting CCL-type chemokines in breast cancer and its milieu: prominent targetable chemokines, CCL8 and CCL21.
Unver N
Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34160019
[TBL] [Abstract][Full Text] [Related]
30. Weighted gene correlation network analysis identifies RSAD2, HERC5, and CCL8 as prognostic candidates for breast cancer.
Tang J; Yang Q; Cui Q; Zhang D; Kong D; Liao X; Ren J; Gong Y; Wu G
J Cell Physiol; 2020 Jan; 235(1):394-407. PubMed ID: 31225658
[TBL] [Abstract][Full Text] [Related]
31. Identification of DRP1 as a prognostic factor correlated with immune infiltration in breast cancer.
Liu B; Fan Y; Song Z; Han B; Meng Y; Cao P; Tan K
Int Immunopharmacol; 2020 Dec; 89(Pt B):107078. PubMed ID: 33049497
[TBL] [Abstract][Full Text] [Related]
32. Integrated analysis identifies TfR1 as a prognostic biomarker which correlates with immune infiltration in breast cancer.
Chen F; Fan Y; Hou J; Liu B; Zhang B; Shang Y; Chang Y; Cao P; Tan K
Aging (Albany NY); 2021 Sep; 13(17):21671-21699. PubMed ID: 34518441
[TBL] [Abstract][Full Text] [Related]
33. SOX13 is a novel prognostic biomarker and associates with immune infiltration in breast cancer.
Gao T; Jiang B; Zhou Y; He R; Xie L; Li Y
Front Immunol; 2024; 15():1369892. PubMed ID: 38707897
[TBL] [Abstract][Full Text] [Related]
34. The Altered Transcriptome and DNA Methylation Profiles of Docetaxel Resistance in Breast Cancer PDX Models.
Gómez-Miragaya J; Morán S; Calleja-Cervantes ME; Collado-Sole A; Paré L; Gómez A; Serra V; Dobrolecki LE; Lewis MT; Diaz-Lagares A; Eroles P; Prat A; Esteller M; González-Suárez E
Mol Cancer Res; 2019 Oct; 17(10):2063-2076. PubMed ID: 31320385
[TBL] [Abstract][Full Text] [Related]
35. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets.
Zhou Y; Zhou B; Pache L; Chang M; Khodabakhshi AH; Tanaseichuk O; Benner C; Chanda SK
Nat Commun; 2019 Apr; 10(1):1523. PubMed ID: 30944313
[TBL] [Abstract][Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
